Synthesis and anti‐inflammatory activity of 8H‐1‐thia‐8‐aza‐dibenzo[e,h]azulenes

Synthesis of a novel class of fused heterotetracyclic compounds, 8H‐1‐thia‐8‐aza‐dibenzo[e,h]azulenes ( VII ), is described. Starting N‐benzoyl‐protected 5H‐dibenzo[b,f]azepine ( XI , PG = Bz) was oxidized to 5‐benzoyl‐10,11‐epoxy‐10,11‐dihydro‐5H‐dibenzo[b,f]azepine ( 2 ), which subsequently rearranged in Lewis acid‐induced epoxide ring opening to give 5‐benzoyl‐5,11‐dihydro‐10H‐dibenzo[b,f]azepin‐10‐one ( 3 ). Vilsmeier reaction of 3 provided β‐chlorovinyl aldehyde 4 that readily cyclized with ethyl 2‐mercaptoacetate to form dibenzazepino[4,5]‐fused thiophene structure 5 . Further transformation of substituent at C‐2 position of 5 and N‐deprotection led to final aminoalkoxy derivatives 9 . All compounds with tetracyclic skeleton were tested in vitro for their anti‐inflammatory activity. J. Heterocyclic Chem., (2011).     

Complete structural and spectral assignment of oxoisoaporphines by HMQC and HMBC experiments

The oxoisoaporphines 2,3‐dihydro‐7H‐dibenzo[de,h]quinolin‐7‐one, 2,3‐dihydro‐5‐methoxy‐7H‐dibenzo [de,h] quinolin‐7‐one, 5‐methoxy‐6‐hydroxy‐2,3‐dihydro‐7H‐dibenzo[de,h]quinolin‐7‐one, 5,6‐dimethoxy‐2,3‐dihydro‐7H‐dibenzo[de,h]quinolin‐7‐one and 5,6‐methylenedi‐oxy‐2,3‐dihydro‐7H‐dibenzo[de,h]quinolin‐7‐one were prepared by cyclization of phenylethylaminophthalides with polyphosphoric acid or by treating 1‐(2‐carboxyphenyl)‐3,4‐dihydroisoquinoline hydrochloride with sulfuric acid at 0 °C. The structures were confirmed and ¹H and ¹³C NMR spectra were completely assigned using a combination of one‐ and two‐dimensional NMR techniques. Copyright © 2003 John Wiley & Sons, Ltd.     

Six polycyclic pyrimidoazepine derivatives: syntheses,molecular structures and supramolecular assembly

A versatile synthetic method has been developed for the formation of variously substituted polycyclic pyrimidoazepine derivatives, formed by nucleophilic substitution reactions on the corresponding chloro‐substituted compounds; the reactions can be promoted either by conventional heating in basic solutions or by microwave heating in solvent‐free systems. Thus, (6RS)‐6,11‐dimethyl‐3,5,6,11‐tetrahydro‐4H‐benzo[b]pyrimido[5,4‐f]azepin‐4‐one, C₁₄H₁₅N₃O, (I), was isolated from a solution containing (6RS)‐4‐chloro‐8‐hydroxy‐6,11‐dimethyl‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepine and benzene‐1,2‐diamine; (6RS)‐4‐butoxy‐6,11‐dimethyl‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepin‐8‐ol, C₁₈H₂₃N₃O₂, (II), was formed by reaction of the corresponding 6‐chloro compound with butanol, and (RS)‐4‐dimethylamino‐6,11‐dimethyl‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepin‐8‐ol, C₁₆H₂₀N₄O, (III), was formed by reaction of the chloro analogue with alkaline dimethylformamide. (6RS)‐N‐Benzyl‐8‐methoxy‐6,11‐dimethyl‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepin‐4‐amine, C₂₂H₂₄N₄O, (IV), (6RS)‐N‐benzyl‐6‐methyl‐1,2,6,7‐tetrahydropyrimido[5′,4′:6,7]azepino[3,2,1‐hi]indol‐8‐amine, C₂₂H₂₂N₄, (V), and (7RS)‐N‐benzyl‐7‐methyl‐2,3,7,8‐tetrahydro‐1H‐pyrimido[5′,4′:6,7]azepino[3,2,1‐ij]quinolin‐9‐amine, C₂₃H₂₄N₄, (VI), were all formed by reaction of the corresponding chloro compounds with benzylamine under microwave irradiation. In each of compounds (I)–(IV) and (VI), the azepine ring adopts a conformation close to the boat form, with the C‐methyl group in a quasi‐equatorial site, whereas the corresponding ring in (V) adopts a conformation intermediate between the twist‐boat and twist‐chair forms, with the C‐methyl group in a quasi‐axial site. No two of the structures of (I)–(VI) exhibit the same range of intermolecular hydrogen bonds: different types of sheet are formed in each of (I), (II), (V) and (VI), and different types of chain in each of (III) and (IV).     

Dihydrooxazolones and dihydroimidazolones derived from acylglycines: syntheses,molecular structures and supramolecular assembly

Syntheses and structures are described for some alkylidene‐substituted dihydrooxazolones and dihydroimidazoles derived from simple acylglycines. A second, triclinic, polymorph of 4‐benzylidene‐2‐(4‐methylphenyl)‐1,3‐oxazol‐5(4H)‐one, C₁₇H₁₃NO₂, (I), has been identified and the structure of 2‐methyl‐4‐[(thiophen‐2‐yl)methylidene]‐1,3‐oxazol‐5(4H)‐one, C₉H₇NO₂S, (II), has been rerefined taking into account the orientational disorder of the thienyl group in each of the two independent molecules. The reactions of phenylhydrazine with 2‐phenyl‐4‐[(thiophen‐2‐yl)methylidene]‐1,3‐oxazol‐5(4H)‐one or 2‐(4‐methylphenyl)‐4‐[(thiophen‐2‐yl)methylidene]‐1,3‐oxazol‐5(4H)‐one yield, respectively, 3‐anilino‐2‐phenyl‐5‐[(thiophen‐2‐yl)methylidene]‐3,5‐dihydro‐4H‐imidazol‐4‐one, C₁₀H₁₅N₃OS, (III), and 3‐anilino‐2‐(4‐methylphenyl)‐5‐[(thiophen‐2‐yl)methylidene]‐3,5‐dihydro‐4H‐imidazol‐4‐one, C₂₁H₁₇N₃OS, (IV), which both exhibit orientational disorder in their thienyl groups. The reactions of 2‐phenyl‐4‐[(thiophen‐2‐yl)methylidene]‐1,3‐oxazol‐5(4H)‐one with hydrazine hydrate or with water yield, respectively, N‐[3‐hydrazinyl‐3‐oxo‐1‐(thiophen‐2‐yl)prop‐1‐en‐2‐yl]benzamide and 2‐(benzoylamino)‐3‐(thiophen‐2‐yl)prop‐2‐enoic acid, which in turn react, respectively, with thiophene‐2‐carbaldehyde to form 2‐phenyl‐5‐[(thiophen‐2‐yl)methylidene]‐3‐{[(E)‐(thiophen‐2‐yl)methylidene]amino}‐3,5‐dihydro‐4H‐imidazol‐4‐one, C₁₉H₁₃N₃OS₂, (V), which exhibits orientational disorder in only one of its thienyl groups, and with methanol to give methyl (2Z)‐2‐(benzoylamino)‐3‐(thiophen‐2‐yl)prop‐2‐enoate, C₁₅H₁₃NO₃S, (VI). There are no direction‐specific intermolecular interactions in the crystal structure of the triclinic polymorph of (I), but the molecules of (II) are linked by two independent C—H...O hydrogen bonds to form C₂²(14) chains. Compounds (III) and (IV) both form centrosymmetric R₂²(10) dimers built from N—H...O hydrogen bonds, while compound (V) forms a centrosymmetric R₂²(10) dimer built from C—H...O hydrogen bonds. In the structure of compound (VI), a combination of N—H...O and C—H...π(arene) hydrogen bonds links the molecules into sheets. Comparisons are made with some similar compounds.     

New pharmaceutical salts containing pyridoxine

Two mixed crystals were obtained by crystallizing the active pharmaceutical ingredient pyridoxine [systematic name: 4,5‐bis(hydroxymethyl)‐2‐methylpyridin‐3‐ol, PN] with (E )‐3‐(4‐hydroxy‐3‐methoxyphenyl)prop‐2‐enoic acid (ferulic acid) and 4‐hydroxy‐3,5‐dimethoxybenzoic acid (syringic acid). PN and the coformers crystallize in the form of pharmaceutical salts in a 1:1 stoichiometric ratio, namely 3‐hydroxy‐4,5‐bis(hydroxymethyl)‐2‐methylpyridin‐1‐ium (E )‐3‐(4‐hydroxy‐3‐methoxyphenyl)prop‐2‐enoate, C₈H₁₂NO₃⁺·C₉H₉O₅⁻, and 3‐hydroxy‐4,5‐bis(hydroxymethyl)‐2‐methylpyridin‐1‐ium 4‐hydroxy‐3,5‐dimethoxybenzoate monohydrate, C₈H₁₂NO₃⁺·C₁₀H₁₁O₅⁻·H₂O, the proton exchange between PN and the acidic partner being supported by the differences of the pK _a values of the two components and by the C—O bond lengths of the carboxylate groups. Besides complex hydrogen‐bonding networks, π–π interactions between aromatic moieties have been found to be important for the packing architecture in both crystals. Hirshfeld surface analysis was used to explore the intermolecular interactions in detail and compare them with the interactions found in similar pyridoxine/carboxylic acid salts.     

Complete 1H and 13C NMR spectral assignment of hydrogenated oxoisoaporphine derivatives

2,3,8,9,10,11‐Hexahydro‐7H‐dibenzo[de,h]quinolin‐7‐one, 5‐methoxy‐2,3,8,9,10,11‐hexahydro‐7H‐dibenzo[de,h]quinolin‐7‐one, 5‐methoxy‐6‐hydroxy‐1,2,3,7a,8,9,10,11,11a,11b‐decahydro‐7H‐dibenzo[de,h]quinolin‐7‐one, 5‐methoxy‐5,6,8,9,10,11‐hexahydro‐4H‐dibenzo[de,h]quinolin‐7‐ol, 5,6,8,9,10,11‐hexahydro‐4H‐dibenzo[de,h]quinolin‐7‐ol and 5,6‐dihydro‐4H‐dibenzo[de,h]quinolin‐7‐ol were prepared by catalytic hydrogenation of oxoisoaporphines or their 2,3‐dihydro derivatives over PtO₂ in acetic acid under mild conditions. Their structures were confirmed and ¹H and ¹³C NMR spectra were completely assigned using a combination of one‐ and two‐dimensional NMR techniques. Copyright © 2003 John Wiley & Sons, Ltd.     

Zolmitriptan oxalate and zolmitriptan camphorsulfonate: the first structural study of salt complexes of the antimigraine drug zolmitriptan

Zolmitriptan hydrogen oxalate [(S)‐dimethyl(2‐{5‐[(2‐oxo‐1,3‐oxazolidin‐4‐yl)methyl]‐1H‐indol‐3‐yl}ethyl)azanium hydrogen oxalate], C₁₆H₂₂N₃O₂⁺·C₂HO₄⁻, (I), and zolmitriptan camphorsulfonate [(S)‐dimethyl(2‐{5‐[(2‐oxo‐1,3‐oxazolidin‐4‐yl)methyl]‐1H‐indol‐3‐yl}ethyl)azanium (S,R)‐{2‐hydroxy‐7,7‐dimethylbicyclo[2.2.1]heptan‐1‐yl}methanesulfonate], C₁₆H₂₂N₃O₂⁺·C₁₀H₁₅O₄S⁻, (II), are the first reported salt complexes of the antimigraine drug zolmitriptan. Compound (I) crystallizes in the space group P2₁ with two molecules of protonated zolmitriptan and two oxalate monoanions in the asymmetric unit, while compound (II) crystallizes in the space group P2₁2₁2₁ with one protonated zolmitriptan molecule and one camphorsulfonate anion in the asymmetric unit. The orientations of the ethylamine side chain and the oxazolidinone ring with respect to the indole ring of the zolmitriptan cation are different for (I) and (II). In (I), they are oriented in opposite directions and the molecule adopts a step‐like appearance, while in (II) the corresponding side chains are folded in the same direction, giving the molecule a cup‐like appearance. The zolmitriptan molecules of (I) form an R₂²(8) dimer, while in (II) they form a helical chain with a C(11) motif. The oxalate monoanions of (I) interact with the zolmitriptan cations and extend the dimer into a three‐dimensional hydrogen‐bonded network. In (II), the camphorsulfonate anion forms an R₂²(15) ring motif with the zolmitriptan cation.     

Two dibenzodiazepinone molecules with dissimilar dimeric associations and apparent different tautomeric forms

In two dibenzodiazepinones, viz. the tricyclic core structure, 5H‐dibenzo[b,e]diazepin‐11(10H)‐one, C₁₃H₁₀N₂O, and an acylated derivative, 1‐(11‐hydroxy‐5H‐dibenzo[b,e]diazepin‐5‐yl)‐2‐{4‐[3‐(1H‐imidazol‐1‐yl)propyl]piperidin‐1‐yl}ethanone ethanol monosolvate, C₂₆H₂₉N₅O₂·C₂H₅OH, dimeric association via hydrogen‐bond bridging between the cyclic amide entities is evident, but there are considerable differences between the parent compound and the amidated derivative. Highly consistent with reported structures of related tricyclic lactams, two molecules of the nonsubstituted compound are bridged through two N—H...O hydrogen bonds across a crystallographic centre of symmetry and the bond lengths of the cyclic amide entity correspond to the amino–oxo (lactam) tautomeric form. In contrast, the structure of the derivative shows two similar, but crystallographically unique, molecules hydrogen bonded into a dimeric unit exhibiting an approximate (noncrystallographic) C2 axis. The bond lengths of the two derivative cyclic amide groups support their potential presence in the hydroxyimine (lactim) tautomeric forms, with the resulting possibility of intermolecular tautomerism. Likely driving forces for the two extreme configurations are discussed.     

Synthesis and Antiplatelet‐Activity Evaluation of α‐Methylidene‐γ‐butyrolactones Bearing 3,4‐Dihydroquinolin‐2(1H)‐one Moieties

In continuation of our search for potent antiplatelet agents, we have synthesized and evaluated several α‐methylidene‐γ‐butyrolactones bearing 3,4‐dihydroquinolin‐2(1H)‐one moieties. O‐Alkylation of 3,4‐dihydro‐8‐hydroxyquinolin‐2(1H)‐one ( 1 ) with chloroacetone under basic conditions afforded 3,4‐dihydro‐8‐(2‐oxopropoxy)quinolin‐2(1H)‐one ( 2a ) and tricyclic 2,3,6,7‐tetrahydro‐3‐hydroxy‐3‐methyl‐5H‐pyrido[1,2,3‐de][1,4]benzoxazin‐5‐one ( 3a ) in a ratio of 1 : 2.84. Their Reformatsky‐type condensation with ethyl 2‐(bromomethyl)prop‐2‐enoate furnished 3,4‐dihydro‐8‐[(2,3,4,5‐tetrahydro‐2‐methyl‐4‐methylidene‐5‐oxofuran‐2‐yl)methoxy]quinolin‐2(1H)‐one ( 4a ), which shows antiplatelet activity, in 70% yield. Its 2′‐Ph derivatives, and 6‐ and 7‐substituted analogs were also obtained from the corresponding 3,4‐dihydroquinolin‐2(1H)‐ones via alkylation and the Reformatsky‐type condensation. Of these compounds, 3,4‐dihydro‐7‐[(2,3,4,5‐tetrahydro‐4‐methylidene‐5‐oxo‐2‐phenylfuran‐2‐yl)methoxy]quinolin‐2(1H)‐one ( 10b ) was the most active against arachidonic acid (AA) induced platelet aggregation with an IC₅₀ of 0.23 μM . For the inhibition of platelet‐activating factor (PAF) induced aggregation, 6‐{[2‐(4‐fluorophenyl)‐2,3,4,5‐tetrahydro‐4‐methylidene‐5‐oxofuran‐2‐yl]methoxy}‐3,4‐dihydroquinolin‐2(1H)‐one ( 9c ) was the most potent with an IC₅₀ value of 1.83 μM .     

Halide salts of antimigraine agents eletriptan and naratriptan

Molecules of eletriptan hydrobromide monohydrate (systematic name: (1S,2R)‐1‐methyl‐2‐{5‐[2‐(phenylsulfonyl)ethyl]‐1H‐indol‐3‐ylmethyl}pyrrolidinium bromide monohydrate), C₂₂H₂₇N₂O₂S⁺·Br⁻·H₂O, (I), and naratriptan hydrochloride (systematic name: 1‐methyl‐4‐{5‐[2‐(methylsulfamoyl)ethyl]‐1H‐indol‐3‐yl}piperidinium chloride), C₁₇H₂₆N₃O₂S⁺·Cl⁻, (II), adopt conformations similar to other triptans. The C‐2 and C‐5 substituents of the indole ring, both of which are in a region of conformational flexibility, are found to be oriented on either side of the indole ring plane in (I), whilst they are on the same side in (II). The N atom in the C‐2 side chain is protonated in both structures and is involved in the hydrogen‐bonding networks. In (I), the water molecules create helical hydrogen‐bonded chains along the c axis. In (II), the hydrogen bonding of the chloride ions results in macrocyclic R₄²(20) and R₄²(24) ring motifs that form sheets in the bc plane. This structural analysis provides an insight into the molecular structure–activity relationships within this class of compound, which is of use for drug development.     

A concise,efficient and versatile synthesis of amino‐substituted benzo[b]pyrimido[5,4‐f]azepines: synthesis and spectroscopic characterization,together with the molecular and supramolecular structures of three products and one intermediate

A concise, efficient and versatile synthesis of amino‐substituted benzo[b]pyrimido[5,4‐f]azepines is described: starting from a 5‐allyl‐4,6‐dichloropyrimidine, the synthesis involves base‐catalysed aminolysis followed by intramolecular Friedel–Crafts cyclization. Four new amino‐substituted benzo[b]pyrimido[5,4‐f]azepines are reported, and all the products and reaction intermediates have been fully characterized by IR, ¹H and ¹³C NMR spectroscopy and mass spectrometry, and the molecular and supramolecular structures of three products and one intermediate have been determined. In each of N,2,6,11‐tetramethyl‐N‐phenyl‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepin‐4‐amine, C₂₂H₂₄N₅, (III), 4‐(1H‐benzo[d]imidazol‐1‐yl)‐6,11‐dimethyl‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepine, which crystallizes as a 0.374‐hydrate, C₂₁H₁₉N₅·0.374H₂O, (VIIIa), and 6,7,9,11‐tetramethyl‐4‐(5‐methyl‐1H‐benzo[d]imidazol‐1‐yl)‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepine, C₂₄H₂₅N₅, (VIIIc), the azepine ring adopts a boat conformation, but with a different configuration at the stereogenic centre in (VIIIc), as compared with (III) and (VIIIa). In the intermediate 5‐allyl‐6‐(1H‐benzo[d]imidazol‐1‐yl)‐N‐methyl‐N‐(4‐methylphenyl)pyrimidin‐4‐amine, C₂₂N₂₁N₅, (VIIb), the immediate precursor of 4‐(1H‐benzo[d]imidazol‐1‐yl)‐6,8,11‐trimethyl‐6,11‐dihydro‐5H‐benzo[b]pyrimido[5,4‐f]azepine, (VIIIb), the allyl group is disordered over two sets of atomic sites having occupancies of 0.688 (5) and 0.312 (5). The molecules of (III) are linked into chains by a C—H…π(pyrimidine) hydrogen bond, and those of (VIIb) are linked into complex sheets by three hydrogen bonds, one of the C—H…N type and two of C—H…π(arene) type. The molecules of the organic component in (VIIIa) are linked into a chain of rings by two C—H…π(arene) hydrogen bonds, and these chains are linked into sheets by the water components; a single weak C—H…N hydrogen bond links molecules of (VIIIc) into centrosymmetric R₂²(10) dimers. Comparisons are made with some related compounds.     

Two conformers of 10,11‐dihydro‐5H‐dibenzo[a,d]cyclo­heptene spiro‐linked with homobenzoquinone epoxide

The crystal structures of the two thermally equilibrated conformational isomers of the epoxide 1′,5′‐dimethyl­spiro[10,11‐dihydro‐5H‐dibenzo[a,d]cyclo­heptene‐5,8′‐4′‐oxatricyclo[5.1.0.0^3,5]octane]‐2′,6′‐dione, C₂₃H₂₀O₃, have been determined by X‐ray diffraction. In the tricyclic dione skeleton, the oxirane and cyclo­propane rings adopt an anti structure with respect to the conjunct quinone frame. The spiro‐linked 10,11‐dihydro‐5H‐dibenzo[a,d]cyclo­heptene ring of the major isomer has a fairly twisted boat form, folding opposite to the adjoining cyclo­propane methyl substituent, whereas the seven‐membered ring of the minor isomer has an almost ideal twist–boat form, inversely folding to the side of the relevant methyl group. The conformational structures of these isomers have been compared with those of the corresponding isomers of the unepoxidized homobenzoquinone.     

Eight salt forms of sulfadiazine

Proton transfer to the sulfa drug sulfadiazine [systematic name: 4‐amino‐N‐(pyrimidin‐2‐yl)benzenesulfonamide] gave eight salt forms. These are the monohydrate and methanol hemisolvate forms of the chloride (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium chloride monohydrate, C₁₀H₁₁N₄O₂S⁺·Cl⁻·H₂O, (I), and 2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium chloride methanol hemisolvate, C₁₀H₁₁N₄O₂S⁺·Cl⁻·0.5CH₃OH, (II)); a bromide monohydrate (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium bromide monohydrate, C₁₀H₁₁N₄O₂S⁺·Br⁻·H₂O, (III)), which has a disordered water channel; a species containing the unusual tetraiodide dianion [bis(2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium) tetraiodide, 2C₁₀H₁₁N₄O₂S⁺·I₄²⁻, (IV)], where the [I₄]²⁻ ion is located at a crystallographic inversion centre; a tetrafluoroborate monohydrate (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium tetrafluoroborate monohydrate, C₁₀H₁₁N₄O₂S⁺·BF₄⁻·H₂O, (V)); a nitrate (2‐{[(4‐azaniumylphenyl)sulfonyl]azanidyl}pyrimidin‐1‐ium nitrate, C₁₀H₁₁N₄O₂S⁺·NO₃⁻, (VI)); an ethanesulfonate {4‐[(pyrimidin‐2‐yl)sulfamoyl]anilinium ethanesulfonate, C₁₀H₁₁N₄O₂S⁺·C₂H₅SO₃⁻, (VII)}; and a dihydrate of the 4‐hydroxybenzenesulfonate {4‐[(pyrimidin‐2‐yl)sulfamoyl]anilinium 4‐hydroxybenzenesulfonate dihydrate, C₁₀H₁₁N₄O₂S⁺·HOC₆H₄SO₃⁻·2H₂O, (VIII)}. All these structures feature alternate layers of cations and of anions where any solvent is associated with the anion layers. The two sulfonate salts are protonated at the aniline N atom and the amide N atom of sulfadiazine, a tautomeric form of the sulfadiazine cation that has not been crystallographically described before. All the other salt forms are instead protonated at the aniline group and on one N atom of the pyrimidine ring. Whilst all eight species are based upon hydrogen‐bonded centrosymetric dimers with graph set R₂²(8), the two sulfonate structures also differ in that these dimers do not link into one‐dimensional chains of cations through NH₃‐to‐SO₂ hydrogen‐bonding interactions, whilst the other six species do. The chloride methanol hemisolvate and the tetraiodide are isostructural and a packing analysis of the cation positions shows that the chloride monohydrate structure is also closely related to these.     

Structural studies of (prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine hetero‐scorpionate copper complexes

The structures of five compounds consisting of (prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine complexed with copper in both the Cu^I and Cu^II oxidation states are presented, namely chlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(I) 0.18‐hydrate, [CuCl(C₁₅H₁₇N₃)]·0.18H₂O, (1), catena‐poly[[copper(I)‐μ₂‐(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ⁵N,N′,N′′:C²,C³] perchlorate acetonitrile monosolvate], {[Cu(C₁₅H₁₇N₃)]ClO₄·CH₃CN}_n, (2), dichlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II) dichloromethane monosolvate, [CuCl₂(C₁₅H₁₇N₃)]·CH₂Cl₂, (3), chlorido{(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II) perchlorate, [CuCl(C₁₅H₁₇N₃)]ClO₄, (4), and di‐μ‐chlorido‐bis({(prop‐2‐en‐1‐yl)bis[(pyridin‐2‐yl)methylidene]amine‐κ³N,N′,N′′}copper(II)) bis(tetraphenylborate), [Cu₂Cl₂(C₁₅H₁₇N₃)₂][(C₆H₅)₄B]₂, (5). Systematic variation of the anion from a coordinating chloride to a noncoordinating perchlorate for two Cu^I complexes results in either a discrete molecular species, as in (1), or a one‐dimensional chain structure, as in (2). In complex (1), there are two crystallographically independent molecules in the asymmetric unit. Complex (2) consists of the Cu^I atom coordinated by the amine and pyridyl N atoms of one ligand and by the vinyl moiety of another unit related by the crystallographic screw axis, yielding a one‐dimensional chain parallel to the crystallographic b axis. Three complexes with Cu^II show that varying the anion composition from two chlorides, to a chloride and a perchlorate to a chloride and a tetraphenylborate results in discrete molecular species, as in (3) and (4), or a bridged bis‐μ‐chlorido complex, as in (5). Complex (3) shows two strongly bound Cl atoms, while complex (4) has one strongly bound Cl atom and a weaker coordination by one perchlorate O atom. The large noncoordinating tetraphenylborate anion in complex (5) results in the core‐bridged Cu₂Cl₂ moiety.     

New Pyrazolyl‐Nicotinic Acids,Methyl Esters,and 1,3,4‐Oxadiazolyl‐pyrazolyl‐pyridine Tricyclic Scaffold Derivatives from 6‐Hydrazinylnicotinic Acid Hydrazide Hydrate

This paper describes an efficient approach for the synthesis of a new series of 6‐[3‐alkyl(aryl/heteroaryl)‐5‐trifluoromethyl‐1H‐pyrazol‐1‐yl]nicotinic acids (where alkyl = CH₃; aryl = Ph, 4‐OCH₃Ph, 4,4′‐BiPh; and heteroaryl = 2‐Furyl) from the hydrolysis reaction of alkyl(aryl/heteroaryl)substituted 2‐(5‐trifluoromethyl‐5‐hydroxy‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)‐5‐(5‐trifluoromethyl‐5‐hydroxy‐4,5‐dihydro‐1H‐1‐carbonylpyrazol‐1‐yl)pyridines, under basic conditions and at 70–95% yields. In a subsequent step, the esterification reaction of pyrazolyl‐nicotinic acids done in thionyl chloride and methanol led to the isolation of a series of methyl 6‐[alkyl(aryl/heteroaryl)‐5‐trifluoromethyl‐1H‐pyrazol‐1‐yl] nicotinates as stable hydrochloride salts at 64–84% yields, which could be easily converted to hydrazides to give new oxadiazolyl‐pyrazolyl‐pyridine tricyclic scaffolds at good yields from a [4 + 1] cyclocondensation reaction with 1,1,1‐triethoxyethane and 1‐(triethoxymethyl)benzene as the reagent/solvent.     

Bases,solvates and salts: new benzimidazole‐ and pyridine‐scaffolded ligands

The intermolecular interactions in the structures of a series of Schiff base ligands have been thoroughly studied. These ligands can be obtained in different forms, namely, as the free base 2‐[(2E)‐2‐(1H‐imidazol‐4‐ylmethylidene)‐1‐methylhydrazinyl]pyridine, C₁₀H₁₁N₅, 1 , the hydrates 2‐[(2E)‐2‐(1H‐imidazol‐2‐ylmethylidene)‐1‐methylhydrazinyl]‐1H‐benzimidazole monohydrate, C₁₂H₁₂N₆·H₂O, 2 , and 2‐{(2E)‐1‐methyl‐2‐[(1‐methyl‐1H‐imidazol‐2‐yl)methylidene]hydrazinyl}‐1H‐benzimidazole 1.25‐hydrate, C₁₃H₁₄N₆·1.25H₂O, 3 , the monocationic hydrate 5‐{(1E)‐[2‐(1H‐1,3‐benzodiazol‐2‐yl)‐2‐methylhydrazinylidene]methyl}‐1H‐imidazol‐3‐ium trifluoromethanesulfonate monohydrate, C₁₂H₁₃N₆⁺·CF₃O₃S^?·H₂O, 5 , and the dicationic 2‐{(2E)‐1‐methyl‐2‐[(1H‐imidazol‐3‐ium‐2‐yl)methylidene]hydrazinyl}pyridinium bis(trifluoromethanesulfonate), C₁₀H₁₃N₅²⁺·2CF₃O₃S^?, 6 . The connection between the forms and the preferred intermolecular interactions is described and further studied by means of the calculation of the interaction energies between the neutral and charged components of the crystal structures. These studies show that, in general, the most important contribution to the stabilization energy of the crystal is provided by π–π interactions, especially between charged ligands, while the details of the crystal architecture are influenced by directional interactions, especially relatively strong hydrogen bonds. In one of the structures, a very interesting example of the nontypical F…O interaction was found and its length, 2.859 (2) Å, is one of the shortest ever reported.     

A Mechanistic Study on the Oxidative Degradation of Dibenzazepine Derivatives by Manganese(III) Complexes in Acidic Sulfate Media

The oxidative degradation of tricyclic antidepressants (TCA) was studied in the presence of a large excess of the oxidizing agent manganese(III) and its reduced form manganese(II) sulfate in acidic media. The products were detected and identified using UV–vis, ESI‐MS, IR, and EPR methods. The mechanism of the reaction was studied for the following two classes of TCA: 10,11‐dihydro‐5H‐dibenz[b, f]azepines and dibenz[b, f]azepines. The oxidative degradation between dibenz[b, f]azepines and the manganese(III) ions resulted in the formation of substituted acridine with the same substituent as in the origin dibenz[b, f]azepine derivative. The pseudo–first‐order rate constants (k_obs) were determined for the degradation process. The dependences of the observed rate constants on the [Mn^III] with a zero intercept were linear. The reaction between 10,11‐dihydro‐5H‐dibenz[b, f]azepines, and the manganese(III) sulfate ion resulted in oxidative dehydrogenation, which proceeded via the formation of the following two intermediates: a free organic radical and a dimer. Further oxidation of the second intermediate led to a positively charged radical dimer as the single final product. Linear dependences of the pseudo–first‐order rate constants (k_obs) on the [Mn^III] with a zero intercept were established for the degradation of 10,11‐dihydro‐5H‐dibenz[b, f]azepines. The observed rate constants were dependent on the [H⁺] and independent of the [TCA] within the excess concentration range of the manganese(III) complexes used in the isolation method. The radical product of the degradation of 10,11‐dihydro‐5H‐dibenz[b, f]azepines was not stable in the aqueous solution and was subsequently transformed to a nonradical dimer in the next slower step. The observed rate constants were independent of the [Mn^III], independent of the [H⁺] and increased slightly with increasing TCA concentrations when TCA was used in excess. The mechanistic consequences of all of these results are discussed.     

A novel binuclear copper complex incorporating a nalidixic acid derivative displaying a one‐dimensional coordination polymeric structure

The identification of the antibacterial action of nalidixic acid (nx) was central to the development of the quinolone antibacterial compounds. The ability of the nx naphthyridyl ring to interact with and inhibit some proteins has encouraged the investigation of similar structures in the search for more active compounds with less adverse effects. The possibility of structural modification by attachment of other biologically active moieties to the naphthyridyl ring of nx allowed the development of new active antimicrobial molecules. Hydrazone derivatives of nx can be synthesized easily based on the condensation of the hydrazide derivative of nx with the desired aldehyde or ketone. Only a few complexes with nx hydrazone derivatives have been described but for none were the crystal structures elucidated. The synthesis of a new one‐dimensional Cu^II coordination polymer, namely catena‐poly[[copper(II)‐di‐μ‐chlorido‐copper(II)‐{μ‐1‐ethyl‐N′‐[(1H‐imidazol‐4‐yl)methylidene]‐7‐methyl‐4‐oxo‐1,4‐dihydro‐1,8‐naphthyridine‐3‐carbohydrazidato}‐[dimethanolcopper(II)]‐{μ‐1‐ethyl‐N′‐[(1H‐imidazol‐3‐yl)methylidene]‐7‐methyl‐4‐oxo‐1,4‐dihydro‐1,8‐naphthyridine‐3‐carbohydrazidato}] dichloride methanol tetrasolvate], {[Cu₃(C₁₆H₁₅N₆O₂)₂Cl₂(CH₃OH)₂]Cl₂·4CH₃OH}_n, with the (1H‐imidazol‐4‐yl)methylidene carbohydrazide derivative of nalidixic acid (denoted h4imi), is presented and its structure is compared to the density functional theory (DFT) optimized structure of free h4imi. The title structure presents an octahedral Cu^II ion on an inversion centre alternating along a polymer chain with a square‐pyramidal Cu^II ion, with the two Cu^II centres bridged by two chloride ligands. Hydrogen bonds involving chloride counter‐ions and methanol solvent molecules mediate the three‐dimensional packing of the polymer. Comparison of the geometrical results from the structure analysis with those derived from a DFT study of the free ligand reveal the differences that arise upon coordination.     

Amitriptylinium picrate: conformational disorder

In the structure of the title salt [systematic name: 3‐(10,11‐dihydro‐5H‐dibenzo[a,d][7]annulen‐5‐ylidene)‐N,N‐dimethylpropan‐1‐aminium 2,4,6‐trinitrophenolate] of a tricyclic antidepressant, C₂₀H₂₄N⁺·C₆H₂N₃O₇⁻, the dimethylaminopropyl subunit possesses a classical static conformational disorder. The central cycloheptadiene ring adopts a bent conformation that is intermediate between boat and chair forms, leading to a butterfly shape for the hetero‐tricyclic moiety. In a complementary fashion, donors from amitriptyline and acceptors from picrate form intermolecular C—H...O hydrogen bonds and N—H...O salt bridges. These hydrogen bonds cluster amitriptyline and picrate ions into a closed R₄⁴(36) hetero‐tetramer, whereas intermolecular C—H...π interactions between amitriptyline ions cluster them into homo‐dimers. Significant π–π stacking interactions are also observed between aromatic rings of amitriptyline and picrate, and these, combined with the C—H...π interactions, associate molecules into linear arrays along the [11] direction.     

Proton‐transfer compounds of 8‐hydroxy‐7‐iodoquinoline‐5‐sulfonic acid (ferron) with 4‐chloroaniline and 4‐bromoaniline

The crystal structures of the proton‐transfer compounds of ferron (8‐hydroxy‐7‐iodoquinoline‐5‐sulfonic acid) with 4‐chloroaniline and 4‐bromoaniline, namely 4‐chloroanilinium 8‐hydroxy‐7‐iodoquinoline‐5‐sulfonate monohydrate, C₆H₇ClN⁺·C₉H₅INO₄S⁻·H₂O, and 4‐bromoanilinium 8‐hydroxy‐7‐iodoquinoline‐5‐sulfonate monohydrate, C₆H₇BrN⁺·C₉H₅INO₄S⁻·H₂O, have been determined. The compounds are isomorphous and comprise sheets of hydrogen‐bonded cations, anions and water molecules which are extended into a three‐dimensional framework structure through centrosymmetric R₂²(10) O—H...N hydrogen‐bonded ferron dimer interactions.